Tumor microenvironment-induced structure changing drug/gene delivery system for overcoming delivery -associated challenges
J Biol Chem 265:80018008 Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W (1993a) Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations
This results in sustained release, better tissue targeting, stronger mitochondrial protection, and improved redox balance.
Proc Natl Acad Sci U S A 117(32):1914119150
Future trials and research will be required to determine whether any findings derived from the FLOW study could benefit a CKD population beyond those studied in the trial, Giullian said
Referral to a dermatologist may be appropriate for diagnostic uncertainty, severe or atypical presentations, suspected scarring alopecia, or cases not improving with conservative management